Key points
- The first indigenous H5N1 (Clade 2.3.2.1a) chicken vaccine was developed by ICAR-NIHSAD, Bhopal, and is dedicated to the nation on November 20.
- The ministry's release says no commercial vaccine now targets this clade, which has caused most chicken outbreaks.
- The release gives no licence, price or supply date, and the Poultry Disease Action Plan 2024 says vaccination against H5 has not been allowed.
India’s first home-made vaccine against bird flu in chickens is being dedicated to the nation on Friday, November 20, at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, where it was developed. Union Agriculture Minister Shivraj Singh Chouhan is performing the dedication, according to the Ministry of Agriculture and Farmers Welfare.
The vaccine is an inactivated vaccine against H5N1 highly pathogenic avian influenza, Clade 2.3.2.1a, the strain the ministry says has caused most chicken outbreaks in the country. What it does not say, in the release issued on November 18, is when poultry farmers can actually use it.
What the ministry says
The release calls it the first vaccine of its kind in India and says no commercial vaccine is available for this clade at present. It is meant to protect birds against the Clade 2.3.2.1a viruses that are circulating in the country.
The ministry sets out the stakes in numbers. Highly pathogenic avian influenza can kill nearly all the birds in an infected flock, and outbreaks bring mass culling and trade restrictions. Since the first detection in India in 2006, more than 500 outbreaks of H5N1 and H5N8 have been reported. The 2006 outbreak is estimated to have caused direct and indirect losses of ₹2,200 to 3,000 crore, and an outbreak in Manipur cost the state losses equal to 0.5% of its GDP.
The release also gives an official estimate that a major outbreak could cut India’s GDP growth by up to 1.5%, and that over 20% of the poultry population could be at risk without control.
The human side is part of the case. Citing the World Health Organization, the ministry says 1,003 human H5N1 cases, including 479 deaths, have been recorded in 25 countries, India among them, since 2003. Clade 2.3.2.1a has also been found in other animals, including mammals, and has caused three human cases.
How the vaccine reached this point
- 2006First H5N1 detection in India; the outbreak costs an estimated ₹2,200 to 3,000 crore
- July 2024Experts advise surveillance and culling with no vaccination, according to reports
- 2024Poultry Disease Action Plan 2024 says vaccination against H5 and H7 has not been allowed
- April 2025After industry asks for vaccination, the department says it needs further scientific evaluation, according to reports
- Nov 18, 2026Ministry announces the dedication of the ICAR-NIHSAD vaccine
- Nov 20, 2026Chouhan dedicates it to the nation in Bhopal
What the release leaves out
The ministry’s release does not say whether the vaccine has a licence, how many doses will be made, who will make them, what they will cost or when they will reach farms. It reports no trial results either. Those are the questions a poultry farmer will ask first.
They matter because of a policy that has stood for years. According to reports, the Poultry Disease Action Plan 2024 says “no vaccination against H5 & H7 has yet been allowed”. The government has approved a vaccine only for the milder H9N2 strain. In July 2024, experts reportedly advised surveillance and culling without vaccination, partly because vaccinated birds can still carry and spread the virus.
In April 2025, after the poultry industry asked for vaccination, the animal husbandry department said the question needed further scientific evaluation, according to reports. Outbreaks are still handled by culling every bird within 1 km of an infected farm, closing nearby shops within 10 km and waiting 90 days before restocking.
So the dedication gives India a domestic vaccine candidate. Whether it also changes the rule that decides if any chicken can be vaccinated is not answered in the release.
Why it matters to farmers and consumers
Culling is the cost poultry farmers know. When an outbreak is confirmed, birds are destroyed, nearby sales stop and a farm sits empty for months. A reported outbreak in Cuddalore, Tamil Nadu, had killed 35,647 birds as of November 13, according to reports, a reminder that the disease is active now and not only in the 2006 record.
Egg and chicken prices follow such disruptions, and trade bans on poultry products follow outbreaks. Our earlier report on food prices, poultry and milk covered how supply shocks reach household budgets.
The public health argument is the second reason officials give. The release links a vaccine for chickens to limiting spread from poultry to other animals and to people, though it gives no evidence yet from field use.
What happens next
The next test is regulatory and practical. A vaccine developed at a public institute needs approval for use, a manufacturer able to produce it in volume, and a decision by the government on whether the action plan changes to allow vaccination against H5. None of the three has been announced.
Farmers and state animal husbandry departments will look for those details after the dedication. Until the ministry publishes them, outbreaks will continue to be handled the way the current plan prescribes: culling and containment, not vaccination.
The documents
- Shri Shivraj Singh Chouhan to dedicate India's First Indigenous H5N1 (Clade 2.3.2.1a) Chicken Vaccine to the Nation on 20 NovemberPress Information Bureau, November 18, 2026
